Balasubramanian / Kumar | Clinical and Molecular Heterogeneity of Osteogenesis Imperfecta | Buch | 978-1-61504-744-4 | sack.de

Buch, Englisch, 63 Seiten, Paperback, Format (B × H): 191 mm x 235 mm, Gewicht: 161 g

Reihe: Colloquium Series on Genomic and Molecular Medicine

Balasubramanian / Kumar

Clinical and Molecular Heterogeneity of Osteogenesis Imperfecta


Erscheinungsjahr 2017
ISBN: 978-1-61504-744-4
Verlag: Morgan & Claypool Life Sciences

Buch, Englisch, 63 Seiten, Paperback, Format (B × H): 191 mm x 235 mm, Gewicht: 161 g

Reihe: Colloquium Series on Genomic and Molecular Medicine

ISBN: 978-1-61504-744-4
Verlag: Morgan & Claypool Life Sciences


Osteogenesis imperfecta (OI) is a disease encompassing a group of disorders mainly characterized by bone fragility and is the commonest form of heritable bone fragility. In this book, the clinical presentations with particular emphasis on rare phenotypes associated with OI are discussed together with molecular advances in diagnosis and treatment of OI. There is a broad spectrum of clinical severity in OI, ranging from multiple fractures in utero and perinatal death, to near-normal adult stature and low fracture incidence. Facial dysmorphism has been noted, but is not well described, nor is it an invariable feature. Sillence et al., in 1979, provided the clinical classification, which has been further expanded. Genetic defects in type 1 collagen can be identified in 85% of patients with a clinical diagnosis of OI, that is, mutations in COL1A1/COL1A2, which follows an autosomal dominant pattern of inheritance. Several genes have now been implicated in autosomal recessive forms of OI and X-linked osteoporosis. Given the possible antenatal presentation and prognosis associated with OI, it is important to make this diagnosis early and be able to distinguish this from other lethal skeletal dysplasias. It is also important to distinguish nonaccidental injury from a pathological cause of fractures, such as OI, and diagnose this promptly in these situations. However, this is not always possible due to variability in presentation and inability to pinpoint the precise genetic etiology despite extensive genetic testing. OI is one such rare genetic condition where treatment is available in the form of bisphosphonates, which has a huge impact on quality of life. Despite advances in medical therapy, multidisciplinary management including physiotherapy remains the mainstay of treatment and improved outcomes in OI.

Balasubramanian / Kumar Clinical and Molecular Heterogeneity of Osteogenesis Imperfecta jetzt bestellen!

Weitere Infos & Material


- Introduction
- The Normal Bone
- Osteogenesis Imperfecta
- Molecular Heterogeneity of OI
- Differential Diagnoses
- Genetic Diagnosis and Management of OI
- Therapeutic Approaches for OI
- Comorbidities
- Prognosis
- Latest Developments
- Conclusions
- References
- Glossary
- Author Biography



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.